Effect of Adding Magnesium Sulphate in Pericapsular Nerve Group Block

• Status: Not yet recruiting
• Trial end date: 2025-03-30
• Target enrollment: 0
• Participant gender: All

Summary

Our aim will be to compare the analgesic efficacy and safety of magnesium sulphate as an adjuvant to bupivacaine in pericapsular nerve group block in Hip joint surgeries.

• Our primary outcome of the study: total amount of postoperative morphine consumption in the first 24h postoperative.

• Our secondary outcome of the study: mean arterial blood pressure, heart rate, respiratory rate, adverse effects, block related complication, sedation score (by Ramsay sedation scale) and pain score (by Visual Analog Scale)

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Bupivacaine; Magnesium Sulfate

Criteria

Inclusion Criteria:

• • Patients aged 18 years or more.

• Patients with American society of anesthesiologists (ASA) classification class I or II

• Patients weight range from 50 to 90 Kgs

Exclusion Criteria:

• • Patient refusal of peripheral nerve block

• Patient with infection at the site of injection

• Patient with coagulopathy

• Patients with known allergy to used medications.